Transgender women (male sex assigned at birth, female gender identity) using hormone treatment show an increased risk of breast cancer compared with the general male population, finds a large Dutch study published by The ...
May 14, 2019
0
24
Thyroid hormones should not be routinely offered to adults with a mildly underactive thyroid gland (known as subclinical hypothyroidism) say a panel of international experts in The BMJ today.
May 14, 2019
0
3
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published ...
May 3, 2019
0
69
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
Apr 30, 2019
0
63
Doctors should ditch the requirement for a mental health assessment of transgender teens and adults before prescribing them hormone treatment, argues an activist and bioethicist, drawing on their own personal experience in ...
Apr 15, 2019
0
1
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.
Apr 3, 2019
0
4
The hormone oxytocin reduces the communication between different brain areas involved in the cognitive, sensory and emotional processing of food cues that people with obesity demonstrate when they look at high-calorie foods, ...
Mar 24, 2019
0
2
The ovaries of transgender men appear to remain functional even after a year of receiving hormonal treatment with testosterone, according to a small Israeli study presented Saturday in the United States.
Mar 23, 2019
1
2
Most women want and expect to have children. But women who have a chronic health condition such as polycystic ovary syndrome (PCOS) often have concerns about childbearing, including whether they can become pregnant.
Feb 8, 2019
0
13
Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence.
Feb 1, 2019
0
3
